MFDS — authorised 19 October 2007
- Marketing authorisation holder: GENZYME
- Status: likely_approved
🇰🇷 Renvela in South Korea
MFDS authorised Renvela on 19 October 2007
Marketing authorisation
Renvela in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Renvela approved in South Korea?
Yes. MFDS authorised it on 19 October 2007.
Who is the marketing authorisation holder for Renvela in South Korea?
GENZYME holds the South Korean marketing authorisation.